(e)Shall comply with the provisions of O.C.G.A. § 43-34-25 regarding prescription drug orders placed by an APRN for a drug or medical device including, but not limited to, the following:1.No prescription drug orders submitted by an APRN for Schedule I or II controlled substances;2.No refills of any drug for more than 12 months from the date of the original Order, except in the case of oral contraceptives, hormone replacement therapy, or prenatal vitamins, which may be refilled for a period of 24 months;3.No drug order or medical device that may result in the performance or occurrence of an abortion, including the administration, prescription or issuance of a drug order that is intended to cause an abortion to occur pharmacologically;4.Written prescription drug orders shall be signed by the APRN, be written on forms that comply with the nurse protocol agreement, and such forms shall contain the information required by paragraph (d) of O.C.G.A. § 43-34-25;5.A written provision in the nurse protocol agreement authorizing the APRN to request, receive, and sign for professional samples, and to distribute them to patients in accordance with a list of professional samples approved by the delegating physician that is maintained by the office or facility where the APRN works and that requires the documentation of each sample received and dispensed; and6.Compliance with applicable state and federal laws and regulations pertaining to the ordering, maintenance, and dispensing of drugs. see full law

(3)Medical Staff Supervision. Programs that do not employ a registered nurse to supervise the nursing staff must ensure that licensed practical nurses adhere to written protocols and are supervised by the Medical Director to ensure that nursing services are being appropriately delivered.(a)Supervision by Medical Director must occur at least one time per month, be documented in writing, reviewed with the Administrator and Clinical Director, and include the following areas:1.the written policies and procedures required in Rule 111-8-53-.15;2.changes made to policies and procedures required in Rule 111-8-53-.15; and3.areas identified by Administrator, Clinical Director, Director of Pharmacy Services, Medical Director or Program Physician as requiring training for all licensed practical nurses; see full law

(10)  Buprenorphine; see full law

(635.1)  Naltrexone; see full law